Nalts Talks About His Days at J&J, His ADHD, and His Merck Performance Review
Kevin Nalty (aka "Nalts" the YouTube video blogger), who last week decided to quit his job as Consumer Product Director at Merck to "follow...
Towards a Rational FDA Policy Addressing the Internet and Social Media
Arnold Friede, Counsel to the law firm McDermott Will & Emery LLP, talks about organizing a collective response from representatives of the pharma industry to FDA's recent enforcement initiative on the use of sponsored links in search ads and more generally, on FDA's overall approach to regulating social media and the Internet.
Was Nalty’s Fart Video the Straw that Broke Merck’s Back or was it Some...
Kevin Nalty (aka "Nalts" the YouTube video blogger) told NewTeeVee's Liz Gannes that "the fact that Merck was recently being unfairly linked to me...
Kevin Nalty Goes Nalts Full Time! Quits Merck to Become Online Video Marketer
May 21, 2009: "Today I quit my day job as Consumer Product Director at Merck, where I marketed Propecia," announced Kevin Nalty, aka YouTube...
The Real Agenda of GSK’s New Blog and Why the Authors’ Identities are Cloaked
The world's second largest drug company, GSK, has followed the lead of the world's most trusted drug company (J&J) and entered the blogosphere and...
Will the Drug Industry be the Next Auto Industry?
At last night's Philama (Philadelphia American Marketing Association PharmaSIG) panel discussion on "Pharmaceutical Marketing within Today's Social Media Culture -- Opportunity or Nightmare?" I...
There IS Life After Pharma!
What is life like after pharma? I asked that question in January, 2009 after more drug industry layoffs made the news. In this podcast, I talk with Marc Douglas, one of the founders of After Pharma, an online resource and community for those seeking opportunities beyond the pharmaceutical industry.
Behrman Wasn’t the First Patient Spokesperson Paid Big Bucks By BMS
Andy Behrman -- aka "Electroboy" -- is being raked over the coals for first shilling for BMS' drug Abilify (for which BMS paid him...
Andy Behrman, Now an Anti-BMS Spokesperson, Says “Ask Your Doctor If Abilify is Wrong...
The saga of the Andy Behrman, the patient that Bristol-Myers Squibb (BMS) paid hundreds of thousands of dollars (but balked at paying him millions)...
It’s a bird…it’s a plane…it’s PharmExec 50, but what’s that molecule?
The May 2009 issue of Pharmaceutical Executive (PE) Magazine is here. It's cover features a 3-D image of a super hero ("50 Man") holding...
